Developing the Hepato-Oncology Workforce

Description

Multidisciplinary care is essential for the optimal management of patients with liver cancer. Hepatologists play a central role in liver cancer care by assessing and managing underlying liver disease. Skills unique to hepatology include stratifying severity of liver disease, identifying and managing portal hypertension, understanding liver metabolism, and managing liver related toxicity of immune and other oncologic therapies.
Workforce demands in hepatology and oncology provide opportunities for cross discipline innovations in discovery and care delivery. In session 2 we will explore the regulatory, logistical, and infrastructural needs of systemic therapy delivery and models of combined specialty training. As the landscape of therapies evolves for liver cancer, we will consider the future of systemic therapy and how the AASLD can promote innovation in the field.

Presentations

11:00 AM - 11:05 AM
Nov 18 2024
San Diego, CA

Introduction

Neehar D. Parikh, MD, MS, FAASLD, Moderator
11:05 AM - 11:20 AM
Nov 18 2024
San Diego, CA

Why Hepatologists Need Focused Training in HCC

Renumathy Dhanasekaran, MD, PhD, Presenter
11:20 AM - 11:40 AM
Nov 18 2024
San Diego, CA

Hepatology Fellowship Training Requirements for Hepato-Oncology

Sumera Ilyas, MD, Presenter
11:40 AM - 11:55 AM
Nov 18 2024
San Diego, CA

Lessons Learned from Neuro-Oncology

Roy E Strowd III, MD, MEd, MS, Presenter
11:55 AM - 12:05 PM
Nov 18 2024
San Diego, CA

My Journey in Hepato-Oncology: Academic Practice

Arndt Vogel, Presenter
12:05 PM - 12:15 PM
Nov 18 2024
San Diego, CA

My Journey in Hepato-Oncology: Community Practice

Mitchell L. Shiffman, Presenter
12:15 PM - 12:30 PM
Nov 18 2024
San Diego, CA

Panel Discussion/Q&A 

Lisa Deng, MD, Moderator

Objectives

  • Outline the requirements for administration of systemic therapies for HCC in the clinical setting
  • Consider lessons learned from neuro-oncology to envision a joint training pathway for hepato-oncology
  • Opportunities for innovative care delivery in HCC
Chair

Mark Yarchoan

Johns Hopkins University
Chair

Tamar Taddei, MD, MD, FAASLD

Yale University